All Stories

  1. Elastic Registration–driven Deep Learning for Longitudinal Assessment of Systemic Sclerosis Interstitial Lung Disease at CT
  2. Guidance production before evidence generation for critical issues: the example of COVID-19
  3. FENO as a biomarker guide for inhaled corticosteroid step down in patients with mild-to-moderate well-controlled asthma
  4. Low-cost, easy-to-build noninvasive pressure support ventilator for under-resourced regions: open source hardware description, performance and feasibility testing
  5. Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis
  6. The DL NO /DL CO ratio: Physiological significance and clinical implications
  7. A European Respiratory Society technical standard: exhaled biomarkers in lung disease
  8. Study of nasal exhaled nitric oxide levels in diagnosis of allergic rhinitis in subjects with and without asthma
  9. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
  10. Standardisation and application of the single-breath determination of nitric oxide uptake in the lung
  11. Utilising exhaled nitric oxide information to enhance diagnosis and therapy of respiratory disease – current evidence for clinical practice and proposals to improve the methodology
  12. The ambition of the European Respiratory Journal continues: chapter 5
  13. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
  14. Should we use gait speed in COPD, FEV1in frailty and dyspnoea in both?
  15. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
  16. Is exhaled nitric oxide a marker of air pollution effect?
  17. Clinical trials: registration and transparency: TABLE 1
  18. Deriving information from external Big Databases and Big Data analytics: all that glitters is not gold
  19. Inhaled nitric oxide decreases pulmonary endothelial nitric oxide synthase expression and activity in normal newborn rat lungs
  20. Study of Exhaled Nitric Oxide in Subjects with Suspected Obstructive Sleep Apnea: A Pilot Study in Vietnam
  21. The ambition of the ERJ: chapter 4
  22. High RhoA expression at the tumor front in clinically localized prostate cancer and association with poor tumor differentiation
  23. Nitrogen monoxide and carbon monoxide transfer interpretation
  24. Should we monitor exhaled NO to assess the restoration of CFTR function in CF patients?
  25. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
  26. A study of exhaled NO (FENO) measurement used to determine asthma control, dose of inhaled corticosteroid and cost in a developing country
  27. «Big Data» et pneumologie
  28. Increased exhaled nitric oxide precedes lung fibrosis in two murine models of systemic sclerosis
  29. Cellular and molecular mechanisms in the pathophysiology of systemic sclerosis
  30. Contribution of exhaled nitric oxide measurement in airway inflammation assessment in asthma. A position paper from the French Speaking Respiratory Society
  31. Increased alveolar nitric oxide concentration is related to nocturnal oxygen desaturation in obstructive sleep apnoea
  32. Cardiovascular comorbidities in obstructive sleep apnoea according to age: a sleep clinic population study
  33. The ambition of the ERJ: chapter 3
  34. How to Assess Alveolar Nitric Oxide
  35. Intérêts des explorations fonctionnelles respiratoires et des études des biomarqueurs dans le diagnostic et le suivi évolutif de la pneumopathie interstitielle diffuse dans la sclérodermie systémique
  36. Le microbiome et les microbiotes respiratoires : des germes et des hommes
  37. Fasudil inhibits prostate cancer-induced angiogenesis in vitro
  38. The role of the RhoA/Rho kinase pathway in anti‑angiogenesis and its potential value in prostate cancer (Review)
  39. Exhaled NO predicts cyclophosphamide response in scleroderma-related lung disease
  40. Integrated care pathways for airway diseases (AIRWAYS-ICPs)
  41. Exhaled nitric oxide concentration and decompression-induced bubble formation: An index of decompression severity in humans?
  42. Early inhaled nitric oxide at high dose enhances rat lung development after birth
  43. Inhaled NO prevents hyperoxia-induced white matter damage in neonatal rats
  44. Prognostic value of six minute walk test in cystic fibrosis adults
  45. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation
  46. Activation of RhoA/Rho-kinase pathway accounts for pulmonary endothelial dysfunction in patients with chronic obstructive pulmonary disease
  47. Parité des sexes et maladies respiratoires
  48. Pathophysiology Updates for Chronic Obstructive Pulmonary Disease
  49. Évolution de la plèvre : de l’anatomie à la physiologie, à travers l’exemple de l’éléphant
  50. Amelioration of Systemic Fibrosis in Mice by Angiotensin II Receptor Blockade
  51. Role of Rho-kinase and its inhibitors in pulmonary hypertension
  52. High alveolar concentration of nitric oxide is associated with alveolitis in scleroderma
  53. Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance
  54. Physiology in respiratory medicine
  55. The editors' farewell and a confident look back to the future
  56. Biologie des systèmes complexes et métabolomique appliqués à la pneumologie
  57. Hypertension pulmonaire : de la physiopathologie moléculaire aux anomalies hémodynamiques
  58. Measuring exhaled nitric oxide in animal models: methods and clinical implications
  59. ERS publications: the flagship and the fleet
  60. A model to predict short-term death or readmission after intensive care unit discharge
  61. Effect of nitric oxide on epithelial ion transports in noncystic fibrosis and cystic fibrosis human proximal and distal airways
  62. European Union Standards for Tuberculosis Care
  63. The European Respiratory Journal makes COPD a priority
  64. Alveolar concentration of nitric oxide predicts pulmonary function deterioration in scleroderma
  65. Autophagie et maladies respiratoires
  66. Whistleblowers
  67. Nitric oxide activity through guanylate cyclase and phosphodiesterase modulation is impaired in fetal lambs with congenital diaphragmatic hernia
  68. ERJ peer reviewers: does this pillar of the Journal's quality need help?
  69. Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis
  70. Clopidogrel protects from cell apoptosis and oxidative damage in a mouse model of renal ischaemia-reperfusion injury
  71. Role of nitric oxide synthases in elastase-induced emphysema
  72. Le vieillissement pulmonaire : de la sénescence cellulaire au déclin de la fonction respiratoire
  73. Increased Alveolar Concentration of Nitric Oxide Is Related to Serum-induced Lung Fibroblast Proliferation in Patients with Systemic Sclerosis
  74. The making of the ERJ: behind the scenes and Editors' cut
  75. Increased Rho-kinase expression and activity and pulmonary endothelial dysfunction in smokers with normal lung function
  76. Multicentre trial evaluating alveolar NO fraction as a marker of asthma control and severity
  77. From the Editors:
  78. Stereology: a bridge to a better understanding of lung structure and function
  79. Les nouvelles recommandations internationales de l’hypertension pulmonaire
  80. Impact factor and its role in academic promotion
  81. Le nouveau souffle de l’acide ribonucléique (ARN) en pathologie respiratoire
  82. Study of prone positioning to reduce ventilator-associated pneumonia in hypoxaemic patients
  83. Refining the changes. Or, how to modify the shape, not the spirit
  84. Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases
  85. Lack of Specificity of the 6-Minute Walk Test as an Outcome Measure for Patients with Systemic Sclerosis
  86. Exhaled nitric oxide, but not serum nitrite and nitrate, is a marker of interstitial lung disease in systemic sclerosis
  87. Détection précoce de la bronchopneumopathie chronique obstructive post-tabagique au Viet Nam
  88. Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments
  89. The ERJ in its 21st year of age: a smooth transition for an everlasting evolution
  90. Congenital diaphragmatic hernia: current status and review of the literature
  91. Modifications épigénétiques et maladies respiratoires : départager l’inné et l’acquis
  92. Pulmonary hypertension: basic concepts and practical management
  93. Neuronal nitric oxide synthase does not contribute to the modulation of pulmonary vascular tone in fetal lambs with congenital diaphragmatic hernia (nNOS in CDH lambs)
  94. Offline Exhaled Nitric Oxide in Emergency Department and Subsequent Acute Asthma Control
  95. TEP-TDM-FDG et diagnostic de malignité des nodules et masses pulmonaires
  96. VENTILATION-INDUCED PULMONARY VASODILATATION IN LAMBS WITH CONGENITAL DIAPHRAGMATIC HERNIA IS MODULATED BY NITRIC OXIDE
  97. O58. Exhaled NO and inflammatory disorders affecting lung alveoli and the distal airways
  98. The association of vascular endothelial growth factor receptor-1 with the risk of cancer progression following radical prostatectomy
  99. Translational research in respiratory medicine
  100. Plasma levels and expression of vascular endothelial growth factor-A in human localized prostate cancer
  101. The expression of vascular endothelial growth factor is associated with the risk of cancer progression after radical prostatectomy
  102. L’hypertension artérielle pulmonaire : de nouveaux concepts pour une « vieille » maladie
  103. Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide
  104. Role of ATP-Dependent Potassium Channels in Pulmonary Vascular Tone of Fetal Lambs With Congenital Diaphragmatic Hernia
  105. Role of vascular endothelial growth factor in prostate cancer
  106. Perfusion pulmonaire, espace mort physiologique et hypertension artérielle pulmonaire à l’exercice : la course au recrutement
  107. Signalisation cellulaire et physiopathologie de l’hypertension artérielle pulmonaire
  108. Reduced exhaled NO is related to impaired nasal potential difference in patients with cystic fibrosis
  109. Serum levels of vascular endothelial growth factor in patients undergoing prostate biopsy for suspicion of prostate cancer
  110. Inhaled nitric oxide therapy in adults: European expert recommendations
  111. High levels of endogenous nitric oxide produced after burn injury in rats arrest activated T lymphocytes in the first G1 phase of the cell cycle and then induce their apoptosis
  112. Neutralizing Ceramide: A Major Breakthrough or Yet Another Marginal Target for the Treatment of Acute Lung Injury?
  113. Physiologie respiratoire
  114. Pro PSA : a “pro cancer” form of PSA?
  115. The hepatopulmonary syndrome: NO way out?
  116. Respiratory monitoring: revisiting classical physiological principles with new tools
  117. Adrenomedullin: a smart road from pheochromocytoma to treatment of pulmonary hypertension
  118. Combination therapy for pulmonary arterial hypertension: still more questions than answers
  119. The hepatopulmonary syndrome: NO way out?: Fig. 1.—
  120. Nitric oxide synthase 1 as a potential modifier gene of decline in lung function in patients with cystic fibrosis
  121. Nitric oxide inhibits spleen cell proliferative response after burn injury by inducing cytostasis, apoptosis, and necrosis of activated T lymphocytes: role of the guanylate cyclase
  122. Altered myosin isoform expression in rat skeletal muscles induced by a changed thyroid state
  123. Severe pulmonary hypertension: walking through new paths to revisit an old field
  124. Successful Cardiopulmonary Resuscitation After Cardiac Arrest as a "Sepsis-Like" Syndrome
  125. Role of tyrosine phosphatase in the modulation of pulmonary vascular tone
  126. The effect of a systemic arteriovenous fistula on the pulmonary arterial blood pressure in the fetal sheep
  127. Treatment with 815-nm diode laser induces long-lasting expression of 72-kDa heat shock protein in normal rat skin
  128. Maturational changes of endothelial vasoactive factors and pulmonary vascular tone at birth
  129. Rôle de la monoxyde d'azote synthase-III et du guanosine 3':5'-monophosphate cyclique dans la protection exercée par le monoxyde d'azote lors d'une ischémie-reperfusion hépatique
  130. Congenital Diaphragmatic Hernia
  131. Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure
  132. Effects of Muscimol or Homotaurine on Sleep–Wake States in Alcohol-Dependent Rats During Withdrawal
  133. Monoxyde d'azote (NO) et asthme
  134. The use, and misuse, of exogenous endothelial-derived vasodilators in acute respiratory failure
  135. Rôles des facteurs vasoactifs synthétisés par l'endothélium dans l'hypertension artérielle pulmonaire
  136. Induction of stress proteins by tobacco smoke in human monocytes: modulation by antioxidants
  137. Exhaled nitric oxide during acute changes of airways calibre in asthma
  138. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats
  139. Role of NO in the pulmonary artery hyporeactivity to phenylephrine in experimental biliary cirrhosis
  140. Endogenous pulmonary nitric oxide production measured from exhaled air is increased in patients with severe cirrhosis
  141. Effects of pretreatment with inhaled methoxamine on bronchial responses to histamine in asthmatic subjects
  142. Protective effects of hsp70 in inflammation
  143. Accuracy assessment for three fiberoptic pulmonary artery catheters for $$S\bar vO_2 $$ monitoring
  144. Lack of efficacy of inhaled nitric oxide in ARDS
  145. Echocardiographic investigation of inhaled nitric oxide in newborn babies with severe hypoxaemia
  146. Rôles du NO en physiopathologie cardiovasculaire et respiratoire
  147. Locally deposited but not inhaled frusemide reduces nasal potential difference in healthy subjects
  148. Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension.
  149. Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome
  150. Measurement of nitrogen dioxide formation from nitric oxide by chemiluminescence in ventilated children
  151. α-Adrenoceptor stimulation of porcine pulmonary arteries
  152. Exercise increases the release of atrial natriuretic peptide in heart transplant recipients
  153. Endothelium-derived relaxing factor and the pulmonary circulation
  154. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
  155. Endothelial dysfunction in vascular disease
  156. Bronchial blood flow and microvascular permeability in the pathophysiology of asthma
  157. Comparative effects of long-term treatment with prostacyclin and its analogue, iloprost, on exercise tolerance of patients with primary pulmonary hypertension
  158. Exercise-induced asthma as a vascular phenomenon
  159. Bronchial effects of alpha2-adrenoceptor agonists and of other antihypertensive agents in asthma
  160. Reduced endothelium-dependent relaxation of cystic fibrosis pulmonary arteries